Market Intelligence · RxIntel

Pharma pricing intelligence

Data-driven insights on India's pharmaceutical market — pricing trends, brand comparisons, and market analysis you won't find anywhere else.

Published

The Semaglutide Demand Explosion

From diabetes therapy to multi-indication metabolic platform

How semaglutide became the fastest-growing drug in pharmaceutical history — and what India's generic wave means for access and pricing.

Coming Soon

Market· In progress

India Generic Wave — 14 Brands in 36 Months

How generic competition reshaped semaglutide pricing in India

Compare· In progress

Ozempic vs Wegovy — Same Molecule, Different Price

Why indication-based pricing creates a 2× cost gap for identical chemistry

Compare· In progress

Oral vs Injectable Semaglutide in India

Rybelsus vs pen vs vial — delivery format as a major cost variable

Market· In progress

GLP-1 India Market — The <1% Opportunity

142M+ diabetics, under 1% GLP-1 penetration — what it means

Live Pricing Data

These insights are built on live pricing data from PriceIQ — compare brands, delivery formats, and manufacturers in real time.

PriceIQ Insights · priceiq.rxintel.link/insights · by RxIntel